Research from Kennedy Trust Senior Research Fellow Anjali Kusumbe’s group at the Kennedy Institute has shown a direct correlation between age-related decline in capillary and artery numbers and hormone production in the endocrine system. Read more here....

Mindful of the importance of clinician scientists and the key role they play in translating discovery into clinical use, the Trust is delighted to announce the launch of its MB PhD scheme. The programme supports aspiring clinician scientists to undertake...

A trial led by Professor Chris Buckley, Kennedy Professor of Translational Rheumatology at the Universities of Oxford and Birmingham, has explored the effectiveness of otilimab in the treatment of rheumatoid arthritis. Read more here....

Professor Marco Fritzsche has been jointly funded by the Kennedy Trust and the Rosalind Franklin Institute to join the Kennedy Institute as the Principal Investigator of the Biophysical Immunology Laboratory (BPI). His lab is leading the development of a lattice...

A study led by Professor Mike Dustin’s group at the Kennedy Institute has visualised how key cells of the immune system lock onto cancerous or infected cells to destroy them. Read more here....

Professor Chris Buckley and Dr Adam Croft at the University of Birmingham’s Rheumatology Research Group have identified the chemical messenger which instructs cells to destroy joints, leading to hope for new treatments. Read the full article here....